Godavari Drugs Limited
GODAVARI.BO
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.42B
Close$
Share Statistics
| Market cap | $1.42 Billion |
|---|---|
| Enterprise Value | $1.42 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $5.43 |
| Beta | 0.35 |
| Outstanding Shares | 10,127,435 |
Return
| Return on Equity | 5.49% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 27.18 |
|---|---|
| PEG | 412.97 |
| Price to Sales | 1.2 |
| Price to Book Ratio | 1.75 |
| Enterprise Value to Revenue | 1.29 |
| Enterprise Value to EBIT | 17.41 |
| Enterprise Value to Net Income | 34 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Godavari Drugs Limited
112 employees
CEO: Mukund Kakani Godavari Drugs Ltd. engages in the manufacture of active pharmaceutical ingredients and its intermediates. Its products include Ciprofloxacin Hydrochloride, Enrofloxacin, Centrizine Hydrochloride, Ethambutol Hydrochloride, A D Lactone, a...